In the management of Erectile Dysfunction, Vacuum Erection Device is most advantageous for patients with

Questions 91

ATI RN

ATI RN Test Bank

Urinary System Multiple Choice Questions Questions

Question 1 of 5

In the management of Erectile Dysfunction, Vacuum Erection Device is most advantageous for patients with

Correct Answer: A

Rationale: Vacuum erection devices (VED) excel in soft glans syndrome engorge glans via negative pressure, aiding rigidity. Post-priapism fibrosis limits VED efficacy poor response. Peyronie's curvature complicates device use painful. Veno-occlusive issues need outflow correction, not just VED less ideal. Soft glans benefit distinguishes VED, key to specific ED management, unlike fibrotic, curved, or outflow cases.

Question 2 of 5

Intraoperative consultation is called by a gynaecologist for possible urinary tract injury during a difficult transabdominal hysterectomy. During inspection clear fluid is noted in the pelvis with ureteral transection on left side. What is the next step?

Correct Answer: A

Rationale: Ureteroureterostomy with DJ stent repairs ureteral transection excises damaged ends, anastomoses, and stents for healing, addressing clear fluid (urine). Observation risks leak/fistula unacceptable. Stent alone won't fix complete cut temporary. Cutaneous ureterostomy is last resort avoidable here. Immediate repair distinguishes it, critical for restoring continuity, unlike passive or palliative options.

Question 3 of 5

What is the commonest form of urinary incontinence in woman aged 40 year?

Correct Answer: A

Rationale: Stress incontinence is commonest at 40 pelvic floor weakening (e.g., childbirth) leaks with pressure (cough). Urgency (overactivity) rises later age-related. Mixed combines both less frequent alone. Continuous suggests fistula rare. Stress's prevalence distinguishes it, critical for midlife women, unlike urgency, combined, or structural causes.

Question 4 of 5

HIVEC' is a newer technique used in the treatment of

Correct Answer: B

Rationale: HIVEC (Hyperthermic Intra-VEsical Chemotherapy) delivers heated chemo (e.g., mitomycin) to bladder targets non-muscle-invasive cancer. Renal cell uses systemic therapy wrong site. Prostate employs radiation/surgery not intravesical. Penile cancer is surgical topical rare. Bladder-specific HIVEC distinguishes it, critical for enhancing chemo efficacy, unlike systemic or external treatments.

Question 5 of 5

All of the following drugs are immune checkpoint inhibitors for treatment of metastatic renal cell carcinoma, Except:

Correct Answer: A

Rationale: Bevacizumab is a VEGF inhibitor blocks angiogenesis, not an immune checkpoint inhibitor (e.g., PD-1/CTLA-4). Pembrolizumab, Ipilimumab, and Nivolumab target immunity enhance T-cell response in metastatic RCC. Bevacizumab's vascular mechanism distinguishes it, critical for differentiating therapies, unlike immune-boosting drugs.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions